Effects of the novel angiotensin II receptor type i antagonist, fimasartan on myocardial ischemia/reperfusion injury

International Journal of Cardiology

Volumn 168, Issue 3, 2013, Pages 2851-2859

  Han, Jin ^a   Park, Sung Ji ^b   Thu, Vu Thi ^a   Lee, Sung Ryul ^a   Long, Le Thanh ^a   Kim, Hyoung Kyu ^a   Kim, Nari ^a   Park, Seung Woo ^b   Jeon, Eun Seok ^b   Kim, Eun Ji ^c   Yoon, Chang Hwan ^c   Cho, Goo Young ^c   Choi, Dong Ju ^c  

^a Inje University   (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

^c Seoul National University Bundang Hospital   (South Korea)

Author keywords

Fimasartan; L type Ca2 + channel; Mitochondrial Ca2 + uniporter; Reperfusion

Indexed keywords

CALCIUM CHANNEL; CALCIUM CHANNEL L TYPE; FIMASARTAN; GLYCOGEN SYNTHASE KINASE 3BETA; MITOCHONDRIAL CALCIUM UNIPORTER; PROTEIN BAX; PROTEIN BCL 2; PROTEIN KINASE B; PROTEIN P53; UNCLASSIFIED DRUG; BIPHENYL DERIVATIVE; PYRIMIDINE DERIVATIVE; TETRAZOLE DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CALCIUM CURRENT; CELL DEATH; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DNA FRAGMENTATION; DRUG MECHANISM; DRUG POTENCY; ECHOCARDIOGRAPHY; ENZYME PHOSPHORYLATION; HEART INFARCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE VOLUME; HEART MUSCLE CELL; HEART PERFORMANCE; HEART PROTECTION; HEART RATE; HYPOXIA; IMMUNOBLOTTING; IN VIVO STUDY; ISCHEMIC PRECONDITIONING; MALE; MEAN ARTERIAL PRESSURE; MEMBRANE POTENTIAL; NICK END LABELING; NONHUMAN; OXYGEN CONSUMPTION; PRIORITY JOURNAL; RAT; REOXYGENATION; REPERFUSION INJURY; ANIMAL; MYOCARDIAL REPERFUSION INJURY; SPRAGUE DAWLEY RAT;

ANIMALS; BIPHENYL COMPOUNDS; MALE; MYOCARDIAL REPERFUSION INJURY; PYRIMIDINES; RATS; RATS, SPRAGUE-DAWLEY; TETRAZOLES;

EID: 84885621693     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2013.03.151     Document Type: Article

References (42)

1. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI) Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction Lancet 1 1986 397 402
2. C.P. Cannon, C.M. Gibson, and C.T. Lambrew Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction JAMA 283 2000 2941 2947
3. P.R. Hansen Myocardial reperfusion injury: experimental evidence and clinical relevance Eur Heart J 16 1995 734 740
4. L. Gomez, B. Li, and N. Mewton Inhibition of mitochondrial permeability transition pore opening: translation to patients Cardiovasc Res 83 2009 226 233
5. G. Kroemer, and J.C. Reed Mitochondrial control of cell death Nat Med 6 2000 513 519
6. G. Solaini, and D.A. Harris Biochemical dysfunction in heart mitochondria exposed to ischaemia and reperfusion Biochem J 390 2005 377 394
7. P. Kossmehl, E. Kurth, and S. Faramarzi Mechanisms of apoptosis after ischemia and reperfusion: role of the renin-angiotensin system Apoptosis 11 2006 347 358
8. M.A. Munger Use of Angiotensin receptor blockers in cardiovascular protection: current evidence and future directions P T 36 2011 22 40
9. F. Correa, V. Soto, and C. Zazueta Mitochondrial permeability transition relevance for apoptotic triggering in the post-ischemic heart Int J Biochem Cell Biol 39 2007 787 798
10. F. Di Lisa, R. Menabo, M. Canton, M. Barile, and P. Bernardi Opening of the mitochondrial permeability transition pore causes depletion of mitochondrial and cytosolic NAD + and is a causative event in the death of myocytes in postischemic reperfusion of the heart J Biol Chem 276 2001 2571 2575
11. T.E. Gunter, D.I. Yule, K.K. Gunter, R.A. Eliseev, and J.D. Salter Calcium and mitochondria FEBS Lett 567 2004 96 102
12. C. Gocmen, E.K. Kumcu, A. Secilmis, P. Ucar, A. Dikmen, and F. Baysal Restorative effects of zinc and selenium on nitrergic relaxations impaired by cadmium in the mouse corpus cavernosum Toxicol Lett 111 2000 229 234
13. J. Garcia-Rivas Gde, K. Carvajal, F. Correa, and C. Zazueta Ru360, a specific mitochondrial calcium uptake inhibitor, improves cardiac post-ischaemic functional recovery in rats in vivo Br J Pharmacol 149 2006 829 837
14. H. Kimura, K. Kawahara, Y. Yamauchi, and J. Miyaki On the mechanisms for the conversion of ventricular fibrillation to tachycardia by perfusion with ruthenium red J Electrocardiol 38 2005 364 370
15. S.-z. Zhang, Q. Gao, C.-m. Cao, I.C. Bruce, and Q. Xia Involvement of the mitochondrial calcium uniporter in cardioprotection by ischemic preconditioning Life Sci 78 2006 738 745
16. J.H. Kim, J.H. Lee, S.H. Paik, and Y.H. Chi Fimasartan, a novel angiotensin II receptor antagonist Arch Pharm Res 35 2012 1123 1126
17. H.W. Lee, M.S. Lim, and S.J. Seong Effect of age on the pharmacokinetics of fimasartan (BR-A-657) Expert Opin Drug Metab Toxicol 7 2011 1337 1344
18. M. Ott, V. Gogvadze, S. Orrenius, and B. Zhivotovsky Mitochondria, oxidative stress and cell death Apoptosis 12 2007 913 922
19. Q. Xu, Z. Ming, A.M. Dart, and X.J. Du Optimizing dosage of ketamine and xylazine in murine echocardiography Clin Exp Pharmacol Physiol 34 2007 499 507
20. B.S. Shin, T.H. Kim, and S.H. Paik Simultaneous determination of fimasartan, a novel antihypertensive agent, and its active metabolite in rat plasma by liquid chromatography-tandem mass spectrometry Biomed Chromatogr 2011 10.1002/bmc.1592
21. B.I. Jugdutt Identification of patients prone to infarct expansion by the degree of regional shape distortion on an early two-dimensional echocardiogram after myocardial infarction Clin Cardiol 13 1990 28 40
22. M. St John Sutton, M.A. Pfeffer, and L. Moye Cardiovascular death and left ventricular remodeling two years after myocardial infarction: baseline predictors and impact of long-term use of captopril: information from the Survival and Ventricular Enlargement (SAVE) trial Circulation 96 1997 3294 3299
23. V.T. Thu, H.K. Kim, and T. Long le NecroX-5 prevents hypoxia/ reoxygenation injury by inhibiting the mitochondrial calcium uniporter Cardiovasc Res 94 2012 342 350
24. S. Miyamoto, A.N. Murphy, and J.H. Brown Akt mediated mitochondrial protection in the heart: metabolic and survival pathways to the rescue J Bioenerg Biomembr 41 2009 169 180
25. Dec;18(6):505-14. CC, in Aov-iCebnic, myocytes. v, et al.
26. J. Yang, H. Jiang, J.W. Ding, L.H. Chen, S. Li, and X.D. Zhang Valsartan preconditioning protects against myocardial ischemia-reperfusion injury through TLR4/NF-kappaB signaling pathway Mol Cell Biochem 330 2009 39 46
27. S. Kano, K. Satoh, S. Kaneta, and K. Ichihara Improvement of stunned myocardium in dogs with olmesartan, an angiotensin II type 1 receptor antagonist, is independent of type 2 receptors Pharmacology 82 2008 22 29
28. D.K. Das, N. Maulik, and R.M. Engelman Redox regulation of angiotensin II signaling in the heart J Cell Mol Med 8 2004 144 152
29. T. Miyashita, and J.C. Reed Tumor suppressor p53 is a direct transcriptional activator of the human bax gene Cell 80 1995 293 299
30. L. Zhu, Y. Yu, B.H. Chua, Y.S. Ho, and T.H. Kuo Regulation of sodium-calcium exchange and mitochondrial energetics by Bcl-2 in the heart of transgenic mice J Mol Cell Cardiol 33 2001 2135 2144
31. X. Yang, M.V. Cohen, and J.M. Downey Mechanism of cardioprotection by early ischemic preconditioning Cardiovasc Drugs Ther 24 2010 225 234
32. S.P. Kunuthur, M.M. Mocanu, B.A. Hemmings, D.J. Hausenloy, and D.M. Yellon The Akt1 isoform is an essential mediator of ischemic preconditioning J Cell Mol Med 16 8 2012 1739 1749
33. F.B. Mehrhof, F.U. Muller, and M.W. Bergmann In cardiomyocyte hypoxia, insulin-like growth factor-I-induced antiapoptotic signaling requires phosphatidylinositol-3-OH-kinase-dependent and mitogen-activated protein kinase-dependent activation of the transcription factor cAMP response element-binding protein Circulation 104 2001 2088 2094
34. J. Inserte, I. Barba, V. Hernando, and D. Garcia-Dorado Delayed recovery of intracellular acidosis during reperfusion prevents calpain activation and determines protection in postconditioned myocardium Cardiovasc Res 81 2009 116 122
35. S.P. Jones, and D.J. Lefer Using gene-targeted mice to investigate the pathophysiology of myocardial reperfusion injury Basic Res Cardiol 95 2000 499 502
36. S. Patergnani, J.M. Suski, and C. Agnoletto Calcium signaling around Mitochondria Associated Membranes (MAMs) Cell Commun Signal 9 2011 19
37. D.A. Brown, and B. O'Rourke Cardiac mitochondria and arrhythmias Cardiovasc Res 88 2010 241 249
38. V.M. Figueredo, K.P. Dresdner Jr., A.C. Wolney, and A.M. Keller Postischaemic reperfusion injury in the isolated rat heart: effect of ruthenium red Cardiovasc Res 25 1991 337 342
39. B.F. Becker, and J. Mobert Low-dose calcium antagonists reduce energy demand and cellular damage of isolated hearts during both ischemia and reperfusion Naunyn Schmiedebergs Arch Pharmacol 360 1999 287 294
40. G. Olivetti, F. Quaini, and R. Sala Acute myocardial infarction in humans is associated with activation of programmed myocyte cell death in the surviving portion of the heart J Mol Cell Cardiol 28 1996 2005 2016
41. P.M. Abadir, D.B. Foster, and M. Crow Identification and characterization of a functional mitochondrial angiotensin system Proc Natl Acad Sci U S A 108 2011 14849 14854
42. R. Ventura-Clapier, A. Garnier, and V. Veksler Transcriptional control of mitochondrial biogenesis: the central role of PGC-1alpha Cardiovasc Res 79 2008 208 217